BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20132172)

  • 1. Variable expression of tenascin-C, osteopontin and fibronectin in inflammatory myofibroblastic tumour of the lung.
    Kaarteenaho R; Sormunen R; Pääkkö P
    APMIS; 2010 Feb; 118(2):91-100. PubMed ID: 20132172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural features of lung fibroblast differentiation into myofibroblasts.
    Kaarteenaho-Wiik R; Paakko P; Sormunen R
    Ultrastruct Pathol; 2009; 33(1):6-15. PubMed ID: 19191196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix.
    Berndt A; Kosmehl H; Katenkamp D; Tauchmann V
    Pathobiology; 1994; 62(2):55-8. PubMed ID: 7524526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung.
    Kaarteenaho-Wiik R; Sademies O; Pääkkö P; Risteli J; Soini Y
    Hum Pathol; 2007 Jan; 38(1):147-53. PubMed ID: 16996565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer-associated myofibroblasts reveal distinctive ultrastructure and function.
    Karvonen HM; Lehtonen ST; Sormunen RT; Lappi-Blanco E; Sköld CM; Kaarteenaho RL
    J Thorac Oncol; 2014 May; 9(5):664-74. PubMed ID: 24662457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief review of the fibronexus and its significance for myofibroblastic differentiation and tumor diagnosis.
    Eyden BP
    Ultrastruct Pathol; 1993; 17(6):611-22. PubMed ID: 8122327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
    Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
    Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron microscopy in the study of myofibroblastic lesions.
    Eyden B
    Semin Diagn Pathol; 2003 Feb; 20(1):13-24. PubMed ID: 12693672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone.
    Romeo S; Eyden B; Prins FA; Briaire-de Bruijn IH; Taminiau AH; Hogendoorn PC
    J Pathol; 2006 Jan; 208(1):26-34. PubMed ID: 16278817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fibronexus in reactive and tumoral myofibroblasts: further characterisation by electron microscopy.
    Eyden B
    Histol Histopathol; 2001 Jan; 16(1):57-70. PubMed ID: 11193213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix proteins: a positive feedback loop in lung fibrosis?
    Blaauboer ME; Boeijen FR; Emson CL; Turner SM; Zandieh-Doulabi B; Hanemaaijer R; Smit TH; Stoop R; Everts V
    Matrix Biol; 2014 Feb; 34():170-8. PubMed ID: 24291458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin expression in relation to stromal tumour cells in canine gastrointestinal epithelial tumours.
    Mukaratirwa S; de Witte E; van Ederen AM; Nederbragt H
    J Comp Pathol; 2003; 129(2-3):137-46. PubMed ID: 12921719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myofibroblast and its tumours.
    Eyden B; Banerjee SS; Shenjere P; Fisher C
    J Clin Pathol; 2009 Mar; 62(3):236-49. PubMed ID: 18930983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibrosarcoma of subcutaneous soft tissue of the cheek.
    Eyden BP; Christensen L; Tagore V; Harris M
    J Submicrosc Cytol Pathol; 1992 Jul; 24(3):307-13. PubMed ID: 1394086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary "inflammatory myofibroblastic" tumors: a critical examination of the diagnostic category based on quantitative immunohistochemical analysis.
    Farris AB; Mark EJ; Kradin RL
    Virchows Arch; 2007 May; 450(5):585-90. PubMed ID: 17372757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibroblasts and extracellular matrix glycoproteins in palmar fibromatosis.
    Magro G; Fraggetta F; Colombatti A; Lanzafame S
    Gen Diagn Pathol; 1997 Feb; 142(3-4):185-90. PubMed ID: 9065582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory pseudotumour of the lung. Immunohistochemical analysis on four new cases.
    Barbareschi M; Ferrero S; Aldovini D; Leonardi E; Colombetti V; Carboni N; Mariscotti C
    Histol Histopathol; 1990 Apr; 5(2):205-11. PubMed ID: 2134374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibroblasts in interstitial lung diseases show diverse electron microscopic and invasive features.
    Karvonen HM; Lehtonen ST; Sormunen RT; Harju TH; Lappi-Blanco E; Bloigu RS; Kaarteenaho RL
    Lab Invest; 2012 Sep; 92(9):1270-84. PubMed ID: 22710982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.
    Jones PL; Cowan KN; Rabinovitch M
    Am J Pathol; 1997 Apr; 150(4):1349-60. PubMed ID: 9094991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.